美国FDA药品溶出方法数据库

药品通用名称	剂型	USP溶出装置	速度	溶出介质	介质体积	建议取样时间（分钟）	更新日期
Imatinib Mesylate	Tablet	II (Paddle)	50	0.1 N HCl	1000	5, 10, 15, 20 and 30	2011/09/22
Imipramine HCl	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Imipramine Pamoate	Capsule	I (Basket)	100	0.1 N HCl without pepsin and with 0.3% pepsin (addition of pepsin is recommended only when significant slow dissolution is observed)	900	30, 60, 90, 120, 150 and 180	2008/01/14
Inavolisib	Tablet	II (Paddle)	50	0.1 N HCl		5, 10, 15, 20, 30, 45 and 60	2026/01/28
Indapamide	Tablet			Refer to USP			2008/04/15
Indinavir Sulfate	Capsule	II (Paddle)	50	0.1 M Citrate Buffer, pH 3.8	900	10, 15, 20 and 30	2004/02/04
Indomethacin	Suspension			Refer to USP			2024/05/31
Indomethacin	Rectal Suppository			Refer to USP			2021/08/26
Indomethacin	Capsule (Extended Release)			Refer to USP			2007/07/25
Indomethacin (40 mg and 20 mg)	Capsule	I (Basket)	100	10 mM citric acid buffer, pH 5.75	750	5, 10, 15, 20 and 30	2015/05/28
Indomethacin (50 and 25 mg)	Capsule			Refer to USP			2015/05/28
Infigratinib Phosphate	Capsule	I (Basket)	100	0.01 N HCl	900	15, 30, 45 and 60	2023/05/18
Iptacopan Hydrochloride	Capsule			Refer to FDA's Dissolution Guidance, 2018			2025/06/23
Irbesartan	Tablet			Refer to USP			2008/08/11
Isavuconazonium Sulfate	Capsule	II (Paddle) with sinker	75	Diluted McIlvaine Buffer [12.5 mM disodium hydrogen phosphate solution +6.25 mM citric acid solution ] + 0.5 % Sodium Lauryl sulfate (SLS)	900	10, 20, 30, 45, 60, 75 and 90	2016/03/17
Isocarboxazid	Tablet	II (Paddle)	50	0.1 N HCl	900	10, 20, 30, 45 and 60	2004/02/04
Isoniazid	Tablet			Refer to USP			2008/04/15
Isosorbide Dinitrate	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Isosorbide Dinitrate	Capsule (Extended Release)			Refer to USP			2015/06/25
Isosorbide Dinitrate	Tablet (Extended Release)			Develop a dissolution method			2024/01/03